Chemoinformaics analysis of 4,4-Dimethyloxetan-2-One
| Molecular Weight | 100.117 | nRot | 0 |
| Heavy Atom Molecular Weight | 92.053 | nRig | 5 |
| Exact Molecular Weight | 100.052 | nRing | 1 |
| Solubility: LogS | -0.841 | nHRing | 1 |
| Solubility: LogP | 1.167 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 15.2883 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.419 |
| Synth | 2.67 |
| Natural Product Likeliness | 1.504 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.383 |
| MDCK | 0.0000417 |
| BBB | 0.987 |
| PPB | 0.267081 |
| VDSS | 0.821 |
| FU | 0.77379 |
| CYP1A2-inh | 0.265 |
| CYP1A2-sub | 0.36 |
| CYP2c19-inh | 0.162 |
| CYP2c19-sub | 0.776 |
| CYP2c9-inh | 0.025 |
| CYP2c9-sub | 0.442 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.369 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.251 |
| CL | 10.324 |
| T12 | 0.791 |
| hERG | 0.008 |
| Ames | 0.021 |
| ROA | 0.034 |
| SkinSen | 0.535 |
| Carcinogencity | 0.477 |
| EI | 0.993 |
| Respiratory | 0.09 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.940861 |